Haiti suffers from both the worst poverty and highest child mortality rates in the Western Hemisphere. The purpose of this investigation was to assess the relationship of child mortality to relative degrees of poverty within Haiti. Method: We conducted a survey of 656 women, 15-45 years of age, living in a particularly poor rural area of southern Haiti. Data was collected regarding living conditions (dwelling size, occupants, construction characteristics, presence of a latrine, and water access) and pregnancy outcome (number of pregnancies, pregnancy losses, stillbirths, and child deaths). Relative poverty, as indicated by living conditions, was compared with pregnancy outcome using pooled and individual variables.
The most frequent causes of chronic renal failure in the first two decades of life are due to urinary tract malformations. Branchio-oto-renal syndrome (BOR) [OMIM 113650 ] is an autosomal dominant developmental disorder of the kidney and urinary tract, accompanied with hearing loss and presenting with a wide intrafamilial variability and reduced penetrance. Dominant mutations in the human homologues of the Drosophila eyes absent gene (EYA1) are frequently the cause of BOR and BO syndromes. EYA1 encodes a 559-amino acid polypeptide with a predicted molecular mass of 61.2 kD. Mutational analysis revealed a novel nonsense mutation in EYA1 as the cause of BOR in this family.
Family JCA7 is of South African Caucasian descent and was identified during routine prenatal ultrasound screening. The proband (II.2) was noted to have absent kidneys and oligohydramnios during this initial screening. A review of the health histories of the family indicated a history of Potter Sequence in a previous pregnancy (II.3) and that the father (I.1) has a unilateral pre-auricular pit with ipsilateral hearing loss. Preliminary renal ultrasound scans of I.1, the mother (I.2) and unaffected daughter (II.1) did not reveal any abnormalities of the urogenital system. Post mortem analysis of II.2 indicated that a solitary dysplastic kidney was present. The infant also presented with a hypoplastic bladder, Potter facies and pulmonary hypoplasia. Based on this evidence we elected to do direct sequencing of the EYA1 gene for mutational analysis. (University of Michigan IRB # 2004 -0322) . Sequence analysis revealed that the patients I.1 and II.2 carried a heterozygous mutation (727GT) affecting the last coding nucleotide of exon 7. Translation of this mutation results in E243X that presumably truncates the full length EYA1 protein by the introduction of a stop codon. The E243X mutation in the affected members of this family should result in a protein product lacking the critical EYA homologous region (EYAhr) encoded by exons 9 through 16. The EYAhr is imperative for the ability of the EYA1 protein product to bind to other proteins, such as SIX1, and regulate transcription properly. Functional analysis is currently being performed in order to assess the mutational effect on binding of protein complex partners and DNA target sequences. Phenotype/genotype correlations are also being investigated as more samples from the kindred become available.
CLINICIAN'S APPROACH TO PERTUSSIS DURING AN OUTBREAK YEAR.
AL Myers, M A Jackson, S Simon, Children's Mercy Hospitals and Clinics, Kansas City, MO, University of Missouri at Kansas City.
BACKGROUND: DTaP was approved for use in the primary vaccine series for US children in 1996. Despite vaccine coverage rates estimated at 85%, as many as 10,000 cases of pertussis are reported annually in the US. In 2004, 79 children in Kansas City, MO had confirmed pertussis infection representing a 3 fold increase compared to 20 prior yrs, and doubling of the prior 4 yrs.
METHODS: Following IRB approval, all cases of pertussis reported by our infection control department were identified. Clinical and epidemiologic data was collected from visit records for infants and children diagnosed with pertussis 1/1/00 -12/31/03 and was compared to data from 1/1/04 -12/ 31/04.
RESULTS: The diagnosis of pertussis was confirmed in 79 children in 2004, compared to an average of 30/yr in 2000 -03, and 20/yr in 1984 -99. The % of children less than 6 mos was similar overall. There was an increase in children Ͼ10 yrs in the 2004 cohort (pϽ0.0001). Hispanic children represented 15% of cases in 2004 (locally 7% of pop), twice as many as the previous 4 yrs combined. The percentage of children receiving state supported health coverage increased from 50% to 68% (pϭ 0.013). More children were seen in the urgent care and ED setting (pϭ0.076).
Typical presentations were recorded for infected children, though omissions in the clinical description were common. 29% of the time, pertussis was not suspected at initial presentation. In those who received pertussis testing, correct treatment was prescribed in 62% of cases. Vaccine status was not recorded in 48% of patients Ͼ2 mos. Contact isolation was discussed in 8% of cases, and household chemoprophylaxis was provided in 51%.
CONCLUSION: Despite good vaccine coverage rates in the US, pertussis continues to be reported; 2004 represented the largest outbreak in the last 30 yrs. Disease was under diagnosed, vaccine status was often not recorded, and household prophylaxis delayed in most cases. The addition of vaccine for adolescents will have some impact, but strategies to improve control should also include increasing DTaP coverage rate for infants, consistent use of a clinical definition to diagnose pertussis, prompt treatment of the index case, and prophylaxis of household contacts.
USE OF NONINVASIVE POSITIVE PRESSURE VENTILATION TO FACILI-TATE EXTUBATION IN PEDIATRIC PATIENTS WITH NEUROMUSCULAR DISEASES.
TA Shah, GR Paul, DJ Birnkrant, Department of Pediatrics, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH.
Introduction: Patients with neuromuscular diseases (NMDs) who require intubation are at risk of extubation failure due to respiratory muscle weakness and they may require tracheostomy. Purpose: To evaluate the use of noninvasive positive pressure ventilation (NPPV) with the BiPAP® (Respironics) device to facilitate extubation of children with NMDs and poor baseline pulmonary function who have been intubated for acute respiratory failure or surgery. Methods: Retrospective chart review, IRB approved. Results: During the time period Jan 2001-Dec 2004, NPPV was used to facilitate extubation for 22 episodes of intubation in 14 patients. Diagnoses: Duchenne muscular dystrophy (Duchenne MD) (7 patients); type 1 spinal muscular atrophy (2 patients); Becker MD (1 patient); congenital MD (1 patient); nemaline myopathy (1 patient); polymyositis (1 patient); acid maltase deficiency (1 patient). Mean age at time of extubation (Ϯ SD): 10.7 Ϯ 5.9 years (range: 1-20 years); 11 of 14 patients were male. Four of 22 episodes of extubation were after spinal surgery. In these patients, mean baseline vital capacity was 47.3 Ϯ 11.4% predicted. In 18 episodes, extubation was after acute respiratory illness with respiratory failure. Mean baseline vital capacity for these patients: 24.5 Ϯ 9.1% predicted (range: 11-38%) (nϭ10, excludes spinal muscular atrophy infants). NPPV was used successfully to facilitate extubation in all 4 episodes of post-surgical extubaton. NPPV was successful in 17 of 18 episodes of extubation during acute respiratory illnesses (94% success rate). At follow-up (mean 27.5 Ϯ 15.2 months after extubation), 2 patients have died (1 patient had Duchenne MD and refused chronic NPPV, 1 patient had acid maltase deficiency). The remaining 12 patients are alive, 9 of whom have no tracheostomy and are using chronic home NPPV. The mean vital capacity at follow-up in these patients is 27.5 Ϯ 14.2% predicted. Two patients are now ventilated with tracheostomy tubes. Conclusion: Patients with severe neuromuscular diseases who have been intubated are at risk for extubation failure and the need for tracheostomy. Our study suggests that, despite highly impaired pulmonary function, NPPV can be used to extubate many of these patients successfully. On long-term follow-up, most of our patients have avoided tracheostomy. Further study is needed to optimize the use of NPPV for patients with NMDs.
PROGNOSTIC FACTORS IN CHILDHOOD NONRHABDOMYOSARCOMA SOFT TISSUE SARCOMAS
Ram Kalpatthi, MD, Frederick B Ruymann, MD, Mohamed Bayoumy, MD, Kathryn J Klopfenstein, MD, Jamil Altaf, MD, Division of Pediatric Hematology/Oncology, Children's Hospital, Columbus, OH Background: Non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) represent about 3% of all childhood malignancies and about 50% of all soft tissue sarcomas. The heterogeneity of these tumors accounts for the paucity of information regarding their natural history and treatment guidelines. Therefore much of the evidence regarding the therapy has been extrapolated from adult studies and few pediatric case series. The purpose of this study is to evaluate our clinical experience with NRSTS in the pediatric population over the past 50 years.
Objectives: To evaluate the prognostic variables, event free survival and overall survival of childhood NRSTS.
Methods: We reviewed the medical records of all patients less than 21 years of age with NRSTS treated at our hospital between 1945 and 2001. Patients with Ewing's family of soft tissue sarcomas were excluded from the analysis. We collected the demographic, disease, histopathology and treatment data of 80 patients in whom all the data were available. The patient's age ranged from 1 month to 20 years (median 11.5 years). The median follow up time was 6 years (1 month to 46 years). Event free survival (EFS) and overall survival (OS) was calculated using Kaplan-Meier survival method.
Results: Of the 80 patients, 34 (42.5%) were able to achieve a complete surgical resection. Forty four (55%) received external beam radiotherapy and adjuvant chemotherapy was given to 57 (71.3%) cases. The EFS was significantly higher for patients with Stage I/II tumors (73%) as compared to Stage III/IV tumors (23%) [EFS, log rank ϭ 18.8, pϽ0.001; OS, log rank ϭ 21.9, pϽ0.001]. Of the different treatment modalities only complete surgical resection had a significant impact on survival (log rank ϭ 8.9, pϽ0.003). Relative to other sites, chest and abdominal tumors had advanced stages (Chi Square ϭ 22.9, p ϭ 0.029). None of the other variables such as age, sex or race impacted survival in our study.
Conclusions: Our data show that surgical resection and tumor stage are the most important prognostic variables in childhood NRSTS. Wide surgical resection of the primary tumor with negative margins continues to be the mainstay of therapy. Radiotherapy and adjuvant chemotherapy should be reserved for patients with inadequate margins or those in whom a complete surgical resection can be facilitated by these modalities.
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